Home > Healthcare > Biotechnology > Biopharma > Cancer Stem Cells Therapy Market

Cancer Stem Cells Therapy Market Size

  • Report ID: GMI7152
  • Published Date: Oct 2023
  • Report Format: PDF

Cancer Stem Cells Therapy Market Size

Cancer Stem Cells Therapy Market size was valued at USD 4.4 billion in 2022 and is estimated to account for USD 12 billion by 2032 due to several factors such as the increasing cases of cancer, growing private and public initiatives and rising awareness regarding availability of stem cell therapy.


Cancer Stem Cells Therapy Market

To understand key trends  
Download Free Sample

For instance, according to World Health Organization (WHO), cancer was the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Therefore, there is a larger patient population in need of effective treatments. Cancer stem cells therapy refers to targeted treatments and therapeutic strategies specifically designed to identify, target, and eliminate cancer stem cells therapy (CSCs) within tumors. Cancer stem cells therapy are a subset of cells within a tumor that exhibit stem cell-like properties, including the ability to self-renew and differentiate into various cell types found in the tumor. These cells are believed to play a significant role in tumor progression, metastasis, and resistance to conventional cancer therapies.


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for cancer stem cells therapy was worth USD 4.4 billion in revenue in 2022 and may record USD 12 billion by end of 2032 due to the increasing cases of cancer along with the growing private and public initiatives

The breast type cancer segment accounted for 24.4% of the market share in 2022 propelled by the increased funding and public awareness

North America industry size is expected to grow at 10% CAGR from 2023-2032 owing to presence of exceptionally advanced healthcare infrastructure, featuring state-of-the-art hospitals, research institutions, and biotechnology companies

Gamida Cells, AbbVie Inc, Astellas Pharma Inc, Novadip Biosciences, ReNeuron Group plc, Celyad, Adna GmBH, Thermo Fisher Scientific, Genentech Inc, and Merck KGaA are some of the major cancer stem cells therapy firms

Cancer Stem Cells Therapy Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 256
  • Countries covered: 19
  • Pages: 120
 Download Free Sample